Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) Amortization of Deferred Charges (2017 - 2026)

Updated

Analysis

Arvinas (ARVN) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.20 Mn
Mar 31, 2026 300,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 3.30 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 400,000.00
Dec 31, 2023 -700,000.00
Sep 30, 2023 500,000.00
Jun 30, 2023 900,000.00
Mar 31, 2023 600,000.00
Dec 31, 2022 500,000.00
Sep 30, 2022 500,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 100,000.00
API Access

Arvinas Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ARVN&period=max&api_key=YOUR_API_KEY